Table 1.
Patient characteristics (N = 303).
| Variable | M (SD)/n (%) | Range |
|---|---|---|
| Age (years) | 58.34 (9.71) | 21–86 |
| Female | 170 (56.11) | |
| Race | ||
| American Indian/Alaska | 3 (1.00) | |
| Native | ||
| Asian | 2 (.66) | |
| Black/African American | 31 (10.23) | |
| White | 265 (87.46) | |
| Other | 2 (.66) | |
| Ethnicity (Hispanic/Latino) | 11 (3.70) | |
| Partnered | 164 (55.59) | |
| Full-time employed | 102 (34.34) | |
| Education (some college or more) | 202 (68.47) | |
| Cigarettes per day | 14.08 (9.89) | 1–70 |
| Smoking-related disease | 148 (48.84) | |
| Smoking-related cancer | 181 (59.74) | |
| Cancer type | ||
| Anal | 4 (1.32) | |
| Bladder | 18 (5.94) | |
| Breast | 77 (25.41) | |
| Cervical | 2 (.66) | |
| Colorectal | 8 (2.64) | |
| Esophageal | 7 (2.31) | |
| Gastric | 1 (.33) | |
| Noncervical gynecologic cancer | 5 (1.65) | |
| Head and neck | 31 (10.23) | |
| Kidney | 8 (2.64) | |
| Liver | 7 (2.31) | |
| Lung | 88 (29.04) | |
| Lymphoma | 9 (2.97) | |
| Melanoma | 6 (1.98) | |
| Pancreatic | 6 (1.98) | |
| Penile | 1 (.33) | |
| Prostate | 23 (7.59) | |
| Small intestinal | 1 (.33) | |
| Testicular | 1 (.33) | |
| Cancer stage | ||
| 0 | 17(6.16) | |
| I | 86 (31.16) | |
| II | 67 (24.28) | |
| III | 53 (19.20) | |
| IV | 53 (19.20) | |
| Indolenta | 3 (.99) | |
| Aggressivea | 5 (1.65) | |
| NA/unknown | 19 (6.27) | |
| Perceived cancer–related benefits of quitting | ||
| (1) Complications of treatments | 8.55 (2.62) | 0–10 |
| (2) Full benefit of treatments | 9.20 (1.95) | 0–10 |
| (3) Recurrence | 8.14 (2.87) | 0–10 |
| (4) New cancer | 8.78 (2.10) | 0–10 |
| Total score | 34.67 (7.20) | 8–40 |
| Quit intentions | 5.90 (1.78) | 1–9 |
SD: standard deviation.
a
Indolent and aggressive are bifurcations used for nonsolid tumors only.